Department of Surgical-Medical Digestive Diseases, Policlinico Umberto I, University La Sapienza, Viale del Policlinico, 00161 Rome, Italy.
Surg Endosc. 2010 May;24(5):1005-10. doi: 10.1007/s00464-009-0715-9. Epub 2009 Oct 29.
This study aimed to compare the efficacy of laparoscopic sleeve gastrectomy (SG) with that of laparoscopic gastric bypass (GBP) and laparoscopic adjustable gastric banding (AGB) for glucose homeostasis in morbidly obese subjects with type 2 diabetes mellitus (T2DM) at a 3-year follow-up assessment and to elucidate the role of weight loss in the T2DM resolution after SG.
For this study, 60 morbidly obese T2DM patients (44 females and 16 males) who underwent AGB (24 patients), GBP (16 patients), or SG (20 patients) between 1996 and 2008 were retrospectively analyzed. Age, sex, body mass index (BMI), estimated weight loss (EWL), fasting glycemia, HbA1c, euglycemic hyperinsulinemic clamp, discontinuation of diabetes treatment, and time until interruption of therapy were evaluated.
In the study, 54 patients received oral hypoglycemic agents for at least 12 months before surgery, and 6 patients received insulin. The mean follow-up period was 36 months. The resolution rate was 60.8% for the AGB patients, 81.2% for the GBP patients, and 80.9% for the SG patients. The postoperative time until interruption of therapy was 12.6 months for the AGB patients, 3.2 months for the GBP patients, and 3.3 months for the SG patients. The hyperinsulinemic euglycemic clamp test was performed 12 months after surgery for the cured patients. Insulin resistance was restored to normal values in all the patients. The greatest improvement from preoperative values occurred in the SG group. For the not-cured GBP and SG patients, an improvement of 120 mg/dl in fasting plasma glucose was observed 3 months after the surgery, suggesting an enhancement in insulin sensitivity, which determines better medical control. The resolution rate remained constant at the 36-month follow-up evaluation in both the GBP and SG groups.
All three bariatric procedures are effective in treating diabetes, with a 3-year follow-up evaluation showing an effect that lasts. The AGB procedure was the least effective. The antidiabetic effect was similarly precocious after GBP and SG compared with AGB. This difference may indicate that a hormonal mechanism may be involved, independent of weight loss.
本研究旨在比较腹腔镜袖状胃切除术(SG)、腹腔镜胃旁路术(GBP)和腹腔镜可调胃束带术(AGB)在 3 年随访评估时对合并 2 型糖尿病(T2DM)的病态肥胖患者葡萄糖稳态的疗效,并阐明 SG 后 T2DM 缓解与体重减轻的关系。
本研究回顾性分析了 1996 年至 2008 年间接受 AGB(24 例)、GBP(16 例)或 SG(20 例)治疗的 60 例病态肥胖 T2DM 患者(女性 44 例,男性 16 例)。评估年龄、性别、体重指数(BMI)、估计减重(EWL)、空腹血糖、HbA1c、正葡萄糖高胰岛素钳夹试验、糖尿病治疗停药、停药时间。
54 例患者术前至少接受 12 个月的口服降糖药物治疗,6 例患者接受胰岛素治疗。平均随访时间为 36 个月。AGB 组的缓解率为 60.8%,GBP 组为 81.2%,SG 组为 80.9%。AGB 组停药时间为 12.6 个月,GBP 组为 3.2 个月,SG 组为 3.3 个月。治愈患者术后 12 个月进行正葡萄糖高胰岛素钳夹试验。所有患者的胰岛素抵抗均恢复正常。SG 组术前值改善最大。对于未治愈的 GBP 和 SG 患者,术后 3 个月空腹血糖改善 120mg/dl,提示胰岛素敏感性增强,从而更好地控制血糖。GBP 和 SG 组在 36 个月的随访评估中,缓解率保持不变。
三种减肥手术均能有效治疗糖尿病,3 年随访评估显示疗效持久。AGB 术式效果最差。与 AGB 相比,GBP 和 SG 术后的降糖作用更早出现。这种差异可能表明存在一种独立于体重减轻的激素机制。